About Hanson Wade
Hanson Wade specializes in bringing people together through outstanding business conferences and year round community contact. We accelerate growth across industry and across the globe. We do this by finding the right people, the right issues, and the right answers to deliver commercial results fast and with less risk.
Within our expanding Fibrosis portfolio of events we also run:
The Anti-Fibrotic Drug Development Summit is the first meeting to assemble researchers and program leaders from cross-industry to share experiences and insights on how to better directly target the fibrotic and inflammatory drivers of these devastating diseases.
The inaugural Idiopathic Pulmonary (IPF) Summit is the only event solely dedicated to transforming discovery & translational fibrosis research into disease modifying IPF therapeutics. This unique IPF meeting is your opportunity to join the leading minds across biopharma and academia to reduce the expansive translational gap that exists in current IPF drug development.
NASH Summit Boston
The 2nd NASH Summit will solve the most pressing challenges drug developers face from discovery to late stage clinical development. Attend this summit to learn the latest insight to identify and validate novel targets, better recapitulate human NASH disease in vivo and confidently diagnose patients.